Sequence 1317(Efungumab)

Sequence Efungumab
Target	Hsp90
Description	MYC-123 , MYC-124 , HSP90MAB , MYC-123A , MYC-123B , Mycograb , Efungumab , MYC-123A MYC-123B MYC-124 HSP90MAB scFv , source : human
Design	Antibody
Chemistry	Amino acids
Sequence	Efungumab single chain variable fragment  : MAEVQLVESGAEVKKPGESLRISCKGSGCIISSYWISWVRQMPGKGLEWMGKIDPGDSYINYSPSFQGHVTISADKSINTAYLQWNSLKASDTAMYYCARGGRDFGDSFDYWGQGTLVTVSSGGGGSGGGGSGGGGSDVVMTQSPSFLSAFVGDRITITCRASSGISRYLAWYQQAPGKAPKLLIYAASTLQTGVPSRFSGSGSGTEFTLTINSLQPEDFATYYCQHLNSYPLTFGGGTKVDIKRAAALEHHHHHHxxxxx :
Application	invasive Candida infection
Name	Efungumab

References

Intrathecal Injections in Children With Spinal Muscular Atrophy: Nusinersen Clinical Trial Experience. Hache M, Swoboda KJ, Sethna N, Farrow-Gillespie A, Khandji A, Xia S, Bishop KM. J Child Neurol. 2016 Jun;31(7):899-906. PubMed:26823478

Background